Halozyme Therapeutics (HALO) Insider Trading & Ownership $55.94 +1.14 (+2.08%) Closing price 01/21/2025 04:00 PM EasternExtended Trading$56.13 +0.19 (+0.34%) As of 08:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$9.16 M Get HALO Insider Trade Alerts Want to know when executives and insiders are buying or selling Halozyme Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HALO Insider Buying and Selling by Quarter Halozyme Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Jeffrey William HendersonDirectorSell10,000$50.01$500,100.00 10/16/2024Michael J LabarreSVPSell10,000$53.26$532,600.00 10/9/2024Helen TorleyCEOSell10,000$52.58$525,800.00 9/25/2024Helen TorleyCEOSell10,000$56.34$563,400.00 9/18/2024Michael J LabarreSVPSell10,000$62.03$620,300.00 9/12/2024Helen TorleyCEOSell10,000$59.20$592,000.00 9/10/2024Helen TorleyCEOSell10,000$59.09$590,900.00 9/9/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$59.24$1,001 - $15,0008/21/2024Michael J LabarreSVPSell10,000$61.75$617,500.00 8/14/2024Matthew L PosardDirectorSell9,881$57.70$570,133.70 8/12/2024Matthew L PosardDirectorSell10,000$55.72$557,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/24/2024Michael J LabarreSVPSell10,000$55.12$551,200.00 7/22/2024Nicole LabrosseCFOSell5,000$53.93$269,650.00 6/27/2024Nicole LabrosseCFOSell10,000$51.93$519,300.00 6/11/2024Matthew L PosardDirectorSell10,000$50.01$500,100.00 5/22/2024Michael J LabarreSVPSell10,000$45.38$453,800.00 4/17/2024Michael J LabarreSVPSell10,000$38.49$384,900.00 3/12/2024Michael J LabarreSVPSell10,000$41.64$416,400.00 2/28/2024Michael J LabarreSVPSell10,000$39.55$395,500.00 (Data available from 1/1/2013 forward) HALO Insider Trading Activity - Frequently Asked Questions Who is on Halozyme Therapeutics's Insider Roster? The list of insiders at Halozyme Therapeutics includes Helen Torley, James M Daly, Jeffrey William Henderson, Matthew L Posard, Michael J Labarre, and Nicole Labrosse. Learn more on insiders at HALO. What percentage of Halozyme Therapeutics stock is owned by insiders? 2.70% of Halozyme Therapeutics stock is owned by insiders. Learn more on HALO's insider holdings. Which Halozyme Therapeutics insiders have been selling company stock? The following insiders have sold HALO shares in the last 24 months: Helen Torley ($5,923,464.86), James M Daly ($874,500.00), Jeffrey William Henderson ($977,200.00), Matthew L Posard ($1,627,433.70), Michael J Labarre ($8,076,600.00), and Nicole Labrosse ($913,331.50). How much insider selling is happening at Halozyme Therapeutics? Insiders have sold a total of 388,467 Halozyme Therapeutics shares in the last 24 months for a total of $18,392,530.06 sold. Which members of congress are trading Halozyme Therapeutics? Josh Gottheimer (D-NJ) has sold shares of Halozyme Therapeutics in the last year totaling $8,000. Halozyme Therapeutics Key ExecutivesDr. Helen I. Torley M.B. Ch. B. (Age 61)M.R.C.P., President, CEO & Director Compensation: $1.82MMs. Nicole LaBrosse (Age 41)Senior VP & CFO Compensation: $849.36k1 recent tradesDr. Michael J. LaBarre Ph.D. (Age 60)Senior VP & CTO Compensation: $843.89kMr. Mark Snyder Esq.Senior VP & Chief Legal OfficerMs. Cortney Caudill M.B.A.Chief Operations OfficerMs. Tram BuiHead of Investor Relations & Corporate CommunicationsMs. Amy Marinne FoxChief Human Resources OfficerMr. Gary GroteChief Commercial OfficerDr. Christopher Wahl M.B.A.M.D., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies BIIB Insider Buying UTHR Insider Buying NBIX Insider Buying INCY Insider Buying BMRN Insider Buying EXEL Insider Buying EXAS Insider Buying RGEN Insider Buying MDGL Insider Buying IONS Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:HALO) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HALO Stock Alerts